Coherus’s Low List Price Adalimumab Stacking Up PBM And Pharmacy Partnerships

Analysts Still Confident In Humira’s Market Share Despite Increasing Competition

 
• By Chloe Kent
  
Yusimry pen and packaging
Two PBMs have agreed to supply Yusimry through the Mark Cuban Cost Plus Drug Company • Source: Coherus Biosciences
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products